Dynavax Technologies | DVAX - Ebitda



Ebitda Alterar Data
AbbVie USD 3.52B 828M 2025-09
Adma Biologics USD 73.59M 14.85M 2025-12
Agenus USD -10.11M 19.02M 2025-03
Amgen USD 5.14B 775M 2025-12
AstraZeneca USD 5.23B 272M 2025-09
Biogen USD 573.2M 253.7M 2025-12
BioMarin Pharmaceutical USD -24.17M 18.91M 2025-12
Bristol-Myers Squibb USD 4.24B 967M 2025-09
Gilead Sciences USD 4.03B 628M 2025-09
Glaxosmithkline GBP 4.75B 1.52B 2025-09
Merck USD 8.39B 1.97B 2025-09
Minerva Neurosciences USD -4.36M 1.71M 2024-09
Nektar Therapeutics USD -31.81M 70K 2023-09
Neurocrine Biosciences USD 218.4M 28.3M 2025-12
Novartis USD 4.77B 1.11B 2025-12
Pfizer USD 6.08B 351M 2025-09
Regeneron Pharmaceuticals USD 1.92B 261.9M 2025-09
Roche Holding CHF 12.68B 2.36B 2024-06
Sarepta Therapeutics USD -168.03M 294.45M 2025-09
TG Therapeutics USD 32.69M 5M 2025-09
Vertex Pharmaceuticals USD 1.44B 100.4M 2025-09